Oral semaglutide has significantly lower bioavailability than injectable semaglutide, so the dose numbers are not comparable
Those who taking semaglutide to treat obesity were more than seven times more likely to receive a diagnosis
4 SURMOUNT-3 study design
Possible mechanisms behind the semaglutide-NAION connection include: Rapid weight loss leading to changes in intracranial pressure Alterations in blood flow to the optic nerve Metabolic changes affecting optic nerve function Its important to note that current research has limitations
Results can vary depending on factors such as metabolism, activity level, age, sleep quality, hormone balance, genetics, and dietary habits
Research in behavioral medicine shows that patients who work with a dietitian or health coach during discontinuation maintain 6075% of their weight loss two years later, compared to 3545% without structured support